BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29758795)

  • 1. Modernizing US regulatory and reimbursement policy to support continued innovation in genomic pathology.
    Walcoff SD; Pfeifer JD
    Per Med; 2012 May; 9(3):295-308. PubMed ID: 29758795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The revitalization of U.S. dental education.
    DePaola DP
    J Dent Educ; 2008 Feb; 72(2 Suppl):28-42. PubMed ID: 18250375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reimbursement and coverage challenges associated with bringing emerging molecular diagnostics into the personalized medicine paradigm.
    Ridge JR
    Per Med; 2006 Aug; 3(3):345-348. PubMed ID: 29788649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. US FDA and personalized medicine: in vitro diagnostic regulatory perspective.
    Težak Ž; Kondratovich MV; Mansfield E
    Per Med; 2010 Sep; 7(5):517-530. PubMed ID: 29776248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic gatekeepers: regulating direct-to-consumer genomic services in an era of participatory medicine.
    Palmer JE
    Food Drug Law J; 2012; 67(4):475-524, iii. PubMed ID: 24640618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of new technology into clinical practice after FDA approval.
    Govil A; Hao SC
    J Interv Card Electrophysiol; 2016 Oct; 47(1):19-27. PubMed ID: 27565971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Harnessing genomics to improve health in India" - an executive course to support genomics policy.
    Acharya T; Kumar NK; Muthuswamy V; Daar AS; Singer PA
    Health Res Policy Syst; 2004 May; 2(1):1. PubMed ID: 15151698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assigning value to medical algorithms: implications for personalized medicine.
    Hornberger J
    Per Med; 2013 Aug; 10(6):577-588. PubMed ID: 29776198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The decline of venture capital investment in early-stage life sciences poses a challenge to continued innovation.
    Fleming JJ
    Health Aff (Millwood); 2015 Feb; 34(2):271-6. PubMed ID: 25646107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
    Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
    Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
    O'Donnell JC
    Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Companion diagnostics and reimbursement system].
    Tazawa Y
    Rinsho Byori; 2013 May; 61(5):435-42. PubMed ID: 23947184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Consultant's intermediary role in the regulation of molecular diagnostics in the US.
    Holloway K; Miller FA
    Soc Sci Med; 2022 Jul; 304():112929. PubMed ID: 32201019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criteria for Drug Reimbursement Decision-Making: An Emerging Public Health Challenge in Bulgaria.
    Iskrov G; Stefanov R
    Balkan Med J; 2016 Jan; 33(1):27-35. PubMed ID: 26966615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of personalized medicine in the disease genomic era.
    Hong KW; Oh B
    BMB Rep; 2010 Oct; 43(10):643-8. PubMed ID: 21034525
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.